Grover's Disease Association with Cutaneous Keratinocyte Cancers: More than a Coincidence?

Grover’s disease basal cell carcinomas cutaneous keratinocyte cancers cutaneous squamous cell carcinomas non-melanoma transient acantholytic dermatosis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Sep 2024
Historique:
received: 07 08 2024
revised: 29 08 2024
accepted: 06 09 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Better mechanistic understanding of desmosome disruption and acantholysis in Grover's disease (GD) may improve management of this disease. Recent molecular studies highlighted promising pathways to be explored by directly comparing GD and selected features of associated skin diseases. The association between GD and cutaneous keratinocyte carcinomas, the most prevalent non-melanoma skin cancers (NMSC), is not completely characterized. To review the medical literature regarding GD-associated cutaneous keratinocyte cancers, focusing on molecular features, pathophysiological mechanisms, and disease associations, to help guide future research and patient management. GD has been associated with a variety of skin conditions, but its association with skin cancers has been rarely reported. Between 1983 and 2024, only nine scientific papers presented data supporting this association. Interestingly, we found that GD may mimic multiple NMSCs, as few authors reported GD cases misdiagnosed as multiple cutaneous squamous cell carcinomas for more than 4 years or the presence of superficial basal cell carcinoma-like areas associated with focal acantholysis. In conclusion: (a) GD may be an imitator of multiple NMSCs, and (b) the relationship between GD and NMSCs may reveal promising pathways for the mechanistic understanding of desmosome disruption and acantholysis in GD and may even lead to its reclassification as a distinctive syndrome.

Identifiants

pubmed: 39273660
pii: ijms25179713
doi: 10.3390/ijms25179713
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Roxana Nedelcu (R)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Derma360 Clinic, 011273 Bucharest, Romania.

Alexandra Dobre (A)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Oncologic Dermatology Department, Elias Emergency University Hospital, 011461 Bucharest, Romania.

Gabriela Turcu (G)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Derma360 Clinic, 011273 Bucharest, Romania.
Dermatology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.

Razvan Andrei (R)

Dermatology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.
Synevo, 014192 Bucharest, Romania.

Elena Balasescu (E)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Florentina Pantelimon (F)

Derma360 Clinic, 011273 Bucharest, Romania.

Mihaela David-Niculescu (M)

Derma360 Clinic, 011273 Bucharest, Romania.
Dermatology Department, "Grigore Alexandrescu" Emergency Pediatric Hospital, 011743 Bucharest, Romania.

Adina Dobritoiu (A)

Derma360 Clinic, 011273 Bucharest, Romania.

Raluca Radu (R)

Dermatology Department, Central Military Emergency Hospital "Dr.Carol Davila", 010242 Bucharest, Romania.

Georgiana Roxana Zaharia (GR)

Dermatology Department, Central Military Emergency Hospital "Dr.Carol Davila", 010242 Bucharest, Romania.

Ionela Hulea (I)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Alice Brinzea (A)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Derma360 Clinic, 011273 Bucharest, Romania.
National Institute for Infectious Diseases "Prof. Dr. Matei Balș", 021105 Bucharest, Romania.

Lorena Manea (L)

Dermatology Department, Pitié-Salpêtrière University Hospital, Public Assistance-Paris Hosiptals-AP-HP-Charles Foix, 75013 Paris, France.

Mihaela Gherghiceanu (M)

Cellular, Molecular Biology & Histology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Ultrastructural Pathology and Bioimaging Lab, Victor Babeş National Institute of Pathology, 050096 Bucharest, Romania.

Daniela Ion (D)

Pathophysiology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH